Home / Inspections / 1198041

FDA Inspection 1198041 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3006188513

The FDA completed an inspection of Octapharma Plasma, Inc. on January 26, 2023 in Springfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 26, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Springfield, IL (United States)

Facility

Other inspections at this facility

  • 1106647 (NAI Wed Jul 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1024599 (NAI Thu Aug 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 944107 (NAI Mon Sep 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 818220 (NAI Fri Jan 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 716428 (NAI Thu Mar 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources